81 FR 65365 - National Institute of Allergy And Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 184 (September 22, 2016)

Page Range		65365-65365
FR Document		2016-22819

Federal Register, Volume 81 Issue 184 (Thursday, September 22, 2016)

[Federal Register Volume 81, Number 184 (Thursday, September 22, 2016)]
[Notices]
[Page 65365]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-22819]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy And Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
    Date: October 26, 2016.
    Time: 9:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Dharmendar Rathore, Ph.D., Senior Scientific 
Review Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G30, National Institutes of Health/NIAID, 5601 
Fishers Lane, Drive, MSC 9823, Bethesda, MD 20892-9823, 240-669-
5058, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 16, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-22819 Filed 9-21-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 184 / Thursday, September 22, 2016 / Notices 65365

multiple distant metastasis as foxp3+ T- Dated: September 16, 2016. DEPARTMENT OF HEALTH AND
cells are generally believed to be critical Carolyn A. Baum, HUMAN SERVICES
to immunotolerance found in cancers. Program Analyst, Office of Federal Advisory
By treating a single local site with this Committee Policy. National Institutes of Health
technology, systemic host immunity [FR Doc. 2016–22812 Filed 9–21–16; 8:45 am]
National Institute of Allergy and
against in situ cancers can be BILLING CODE 4140–01–P Infectious Diseases; Notice of Closed
dramatically activated, leading to rapid
Meeting
tumor regression at the treated lesion as
well as distant metastatic lesions DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the
untreated with the near infrared light HUMAN SERVICES Federal Advisory Committee Act, as
while inducing minimal side effects. amended (5 U.S.C. App.), notice is
National Institutes of Health hereby given of the following meeting.
The prospective exclusive license will
The meeting will be closed to the
be royalty bearing and will comply with National Institute of Allergy And public in accordance with the
the terms and conditions of 35 U.S.C. Infectious Diseases; Notice of Closed provisions set forth in sections
209 and 37 CFR part 404.7. The Meeting 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
prospective exclusive license may be as amended. The contract proposals and
granted unless within fifteen (15) days Pursuant to section 10(d) of the the discussions could disclose
from the date of this published notice, Federal Advisory Committee Act, as confidential trade secrets or commercial
the National Cancer Institute receives amended (5 U.S.C. App.), notice is property such as patentable material,
written evidence and argument that hereby given of the following meeting. and personal information concerning
establishes that the grant of the license individuals associated with the contract
The meeting will be closed to the
would not be consistent with the proposals, the disclosure of which
public in accordance with the
requirements of 35 U.S.C. 209 and 37 would constitute a clearly unwarranted
provisions set forth in sections
CFR part 404.7. invasion of personal privacy.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Complete applications for a license in as amended. The contract proposals and Name of Committee: National Institute of
the prospective field of use that are filed Allergy and Infectious Diseases Special
the discussions could disclose
in response to this notice will be treated Emphasis Panel; NIAID Peer Review Meeting.
confidential trade secrets or commercial Date: October 13, 2016.
as objections to the grant of the property such as patentable material, Time: 8:00 a.m. to 5:00 p.m.
contemplated Exclusive Patent License and personal information concerning Agenda: To review and evaluate contract
Agreement. Comments and objections individuals associated with the contract proposals.
submitted to this notice will not be proposals, the disclosure of which Place: National Institutes of Health, 5601
made available for public inspection would constitute a clearly unwarranted Fishers Lane, Rockville, MD 20892
and, to the extent permitted by law, will (Telephone Conference Call).
invasion of personal privacy. Contact Person: Jay Bruce Sundstrom,
not be released under the Freedom of
Name of Committee: National Institute of Ph.D., Scientific Review Officer, Scientific
Information Act, 5 U.S.C. 552. Review Program, Division of Extramural
Allergy and Infectious Diseases Special
Dated: September 16, 2016. Emphasis Panel; NIAID Peer Review Meeting. Activities, Room 3G11A, National Institutes
Richard U. Rodriguez, Date: October 26, 2016. of Health/NIAID, 5601 Fishers Lane, MSC
Time: 9:30 a.m. to 12:30 p.m. 9823, Bethesda, MD 20892–9823, 240–669–
Associate Director, Technology Transfer 5045, sundstromj@niaid.nih.gov.
Center, National Cancer Institute. Agenda: To review and evaluate contract
proposals. (Catalogue of Federal Domestic Assistance
[FR Doc. 2016–22820 Filed 9–21–16; 8:45 am] Program Nos. 93.855, Allergy, Immunology,
Place: National Institutes of Health, 5601
BILLING CODE 4140–01–P and Transplantation Research; 93.856,
Fishers Lane, Rockville, MD 20892
Microbiology and Infectious Diseases
(Telephone Conference Call). Research, National Institutes of Health, HHS)
Contact Person: Dharmendar Rathore,
DEPARTMENT OF HEALTH AND Dated: September 15, 2016.
Ph.D., Senior Scientific Review Officer,
HUMAN SERVICES Scientific Review Program, Division of Natasha M. Copeland,
Extramural Activities, Room 3G30, National Program Analyst, Office of Federal Advisory
National Institutes of Health Committee Policy.
Institutes of Health/NIAID, 5601 Fishers
Lane, Drive, MSC 9823, Bethesda, MD [FR Doc. 2016–22818 Filed 9–21–16; 8:45 am]
National Institute of Mental Health;
20892–9823, 240–669–5058, rathored@ BILLING CODE 4140–01–P
Cancellation of Meeting
mail.nih.gov.
Notice is hereby given of the (Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology, DEPARTMENT OF HEALTH AND
cancellation of the National Institute of
and Transplantation Research; 93.856, HUMAN SERVICES
Mental Health Special Emphasis Panel,
Microbiology and Infectious Diseases
September 14, 2016, 10:00 a.m. to National Institutes of Health
Research, National Institutes of Health, HHS)
September 14, 2016, 11:00 a.m.,
National Institutes of Health, NSC, 6001 Dated: September 16, 2016. National Institute of Neurological
asabaliauskas on DSK3SPTVN1PROD with NOTICES

Executive Boulevard, Bethesda, MD Natasha M. Copeland, Disorders and Stroke; Notice of Closed
20892 which was published in the Program Analyst, Office of Federal Advisory Meeting
Federal Register on August 30, 2016, 81 Committee Policy. Pursuant to section 10(d) of the
FR 59643. [FR Doc. 2016–22819 Filed 9–21–16; 8:45 am] Federal Advisory Committee Act, as
The meeting notice is being cancelled BILLING CODE 4140–01–P amended (5 U.S.C. App.), notice is
due to reviewer conflicts. The review hereby given of the following meeting.
will be rescheduled. The meeting will be closed to the
public in accordance with the

VerDate Sep<11>2014 18:58 Sep 21, 2016 Jkt 238001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\22SEN1.SGM 22SEN1

Document Created: 2016-09-22 01:03:23
Document Modified: 2016-09-22 01:03:23

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 26, 2016.
FR Citation		81 FR 65365

81 FR 65365 - National Institute of Allergy And Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 184 (September 22, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health